CRCT(CRCT)
CRCT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $677M | $682M | $687M |
| Low | $667M | $672M | $669M |
| High | $688M | $693M | $705M |
| EBITDA Avg | $157M | $158M | $159M |
| Low | $154M | $155M | $155M |
| High | $159M | $160M | $163M |
| EBIT Avg | $118M | $119M | $119M |
| Low | $116M | $117M | $116M |
| High | $119M | $120M | $122M |
| Net Income Avg | $42M | $42M | $41M |
| Low | $41M | $42M | $40M |
| High | $43M | $43M | $42M |
| EPS Avg | $0.19 | $0.20 | $0.19 |
| Low | $0.19 | $0.19 | $0.19 |
| High | $0.20 | $0.20 | $0.19 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $164M | $194M | $155M | $196M | $204M | $212M |
| Low | $164M | $194M | $155M | $196M | $204M | $212M |
| High | $164M | $194M | $155M | $196M | $204M | $212M |
| EBITDA Avg | $38M | $45M | $36M | $45M | $47M | $49M |
| Low | $38M | $45M | $36M | $45M | $47M | $49M |
| High | $38M | $45M | $36M | $45M | $47M | $49M |
| EBIT Avg | $29M | $34M | $27M | $34M | $35M | $37M |
| Low | $29M | $34M | $27M | $34M | $35M | $37M |
| High | $29M | $34M | $27M | $34M | $35M | $37M |
| Net Income Avg | $6M | $2M | $17M | $13M | $10M | $3M |
| Low | $6M | $2M | $17M | $13M | $10M | $3M |
| High | $6M | $2M | $17M | $13M | $10M | $3M |
| EPS Avg | $0.03 | $0.01 | $0.08 | $0.06 | $0.04 | $0.02 |
| Low | $0.03 | $0.01 | $0.08 | $0.06 | $0.04 | $0.02 |
| High | $0.03 | $0.01 | $0.08 | $0.06 | $0.04 | $0.02 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |